Search

everythinglearnresearchcommunity

for

Search:↓

PRP injection for hair growth can cause reversible vision loss due to inflammatory optic neuropathy.

Adipose tissue-derived exosomes may help treat lichen planopilaris and preserve hair.

Oral minoxidil can cause dry mouth, but switching to topical minoxidil may prevent this side effect.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

Follicular porokeratosis may be linked to diabetes and can lead to hair loss.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Pilomatricoma is a rare, benign skin tumor that requires surgical removal for best results.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Recognizing rare hair loss patterns in young females can improve understanding and treatment.

Early detection of tinea capitis is possible by spotting specific hair patterns like comma or corkscrew hairs.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Complete surgical removal and regular check-ups are essential for treating a rare skin cancer, and hair transplant can help fix scars from cancer surgery.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Antioxidants can block the cancer-fighting effects of doxorubicin.

CS12192 effectively treats alopecia areata with better safety than current options.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Blocking LFA-1 prevents hair loss in mice.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.